136 related articles for article (PubMed ID: 8338947)
1. Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method.
Inbal A; Englender T; Kornbrot N; Randi AM; Castaman G; Mannucci PM; Sadler JE
Blood; 1993 Aug; 82(3):830-6. PubMed ID: 8338947
[TBL] [Abstract][Full Text] [Related]
2. Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families.
Inbal A; Seligsohn U; Kornbrot N; Brenner B; Harrison P; Randi A; Rabinowitz I; Sadler JE
Thromb Haemost; 1992 Jun; 67(6):618-22. PubMed ID: 1324533
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.
Randi AM; Rabinowitz I; Mancuso DJ; Mannucci PM; Sadler JE
J Clin Invest; 1991 Apr; 87(4):1220-6. PubMed ID: 2010538
[TBL] [Abstract][Full Text] [Related]
4. Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.
Lavergne JM; De Paillette L; Bahnak BR; Ribba AS; Fressinaud E; Meyer D; Pietu G
Br J Haematol; 1992 Sep; 82(1):66-72. PubMed ID: 1419804
[TBL] [Abstract][Full Text] [Related]
5. Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB.
Piétu G; Ribba AS; de Paillette L; Chérel G; Lavergne JM; Bahnak BR; Meyer D
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):415-21. PubMed ID: 1420817
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
Ginsburg D; Konkle BA; Gill JC; Montgomery RR; Bockenstedt PL; Johnson TA; Yang AY
Proc Natl Acad Sci U S A; 1989 May; 86(10):3723-7. PubMed ID: 2786201
[TBL] [Abstract][Full Text] [Related]
7. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
[TBL] [Abstract][Full Text] [Related]
8. Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type IIB von Willebrand disease.
Ribba AS; Lavergne JM; Bahnak BR; Derlon A; Piétu G; Meyer D
Blood; 1991 Oct; 78(7):1738-43. PubMed ID: 1912563
[TBL] [Abstract][Full Text] [Related]
9. Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease.
Sugiura I; Matsushita T; Tanimoto M; Takahashi I; Yamazaki T; Yamamoto K; Takamatsu J; Kamiya T; Saito H
Thromb Haemost; 1992 Jun; 67(6):612-7. PubMed ID: 1380739
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
11. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.
Kroner PA; Kluessendorf ML; Scott JP; Montgomery RR
Blood; 1992 Apr; 79(8):2048-55. PubMed ID: 1373334
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
[TBL] [Abstract][Full Text] [Related]
13. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr).
Iannuzzi MC; Hidaka N; Boehnke M; Bruck ME; Hanna WT; Collins FS; Ginsburg D
Am J Hum Genet; 1991 Apr; 48(4):757-63. PubMed ID: 1673047
[TBL] [Abstract][Full Text] [Related]
15. New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami.
Ledford MR; Rabinowitz I; Sadler JE; Kent JW; Civantos F
Blood; 1993 Jul; 82(1):169-75. PubMed ID: 8324222
[TBL] [Abstract][Full Text] [Related]
16. Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease.
Ribba AS; Christophe O; Derlon A; Cherel G; Siguret V; Lavergne JM; Girma JP; Meyer D; Pietu G
Blood; 1994 Feb; 83(3):833-41. PubMed ID: 8298143
[TBL] [Abstract][Full Text] [Related]
17. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.
Eikenboom JC; Matsushita T; Reitsma PH; Tuley EA; Castaman G; Briët E; Sadler JE
Blood; 1996 Oct; 88(7):2433-41. PubMed ID: 8839833
[TBL] [Abstract][Full Text] [Related]
18. Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease.
Gaucher C; Hanss M; Dechavanne M; Mazurier C
Br J Haematol; 1993 Jan; 83(1):94-9. PubMed ID: 8435341
[TBL] [Abstract][Full Text] [Related]
19. An alternative strategy for identification of type IIA VWD mutations.
Winter PC; Mayne EE
Br J Haematol; 1993 Jul; 84(3):521-3. PubMed ID: 8217803
[TBL] [Abstract][Full Text] [Related]
20. A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD.
Siguret V; Lavergne JM; Chérel G; Boyer-Neumann C; Ribba AS; Bahnak BR; Meyer D; Piétu G
Hum Genet; 1994 Feb; 93(2):95-102. PubMed ID: 7906671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
